Photo taken from Genomate Health/LinkedIn
Jul 6, 2024, 02:19
Advancing the fight against rare cancers – Genomate Health
Genomate Health shared on LinkedIn:
“At Genomate Health, we are dedicated to advancing the fight against rare cancers, includingsarcoma and bone cancer.
This month, we shine a spotlight on these often-overlooked cancers to raise awareness and support for patients and their families.
Sarcomas and bone cancers are rare but aggressive, requiring innovative and precise treatment approaches.
Our flagship product, Genomate, utilizes computational reasoning to deliver personalized treatment plans based on each patient’s unique genetic profile, providing hope for those battling these challenging cancers.
Learn more about our solutions.”
Source: Genomate Health/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43